Effects of growth hormone reduction in a patient with polycystic ovary syndrome complicated with acromegaly

Junko Goto, Fumio Otsuka, Kenichi Inagaki, Naoko Tsukamoto, Jiro Suzuki, Tomoko Miyoshi, Toshio Ogura, Yasuhiko Kamada, Hirofumi Makino

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We report a rare case of polycystic ovary syndrome (PCOS) complicated with acromegaly due to a growth hormone (GH)-producing pituitary adenoma. Complete removal of the pituitary adenoma successfully reduced circulating levels of GH and insulin-like growth factor (IGF)-l, which, in turn, resulted in the amelioration of gonadal dysfunction, hyperandrogenism, lutenizing hormone hypersecretion, and severe insulin resistance. This clinical complication suggests that activation of systemic GH-IGF-1 axis is potentially involved in the development of PCOS.

Original languageEnglish
Pages (from-to)157-160
Number of pages4
JournalEndocrine Journal
Volume56
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Acromegaly
Polycystic Ovary Syndrome
Growth Hormone
Pituitary Neoplasms
Somatomedins
Hyperandrogenism
Luteinizing Hormone
Insulin Resistance

Keywords

  • Acromegaly
  • Growth hormone
  • Hyperglycemia
  • Insulin-like growth factor-1
  • Polycystic ovary syndrome

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effects of growth hormone reduction in a patient with polycystic ovary syndrome complicated with acromegaly. / Goto, Junko; Otsuka, Fumio; Inagaki, Kenichi; Tsukamoto, Naoko; Suzuki, Jiro; Miyoshi, Tomoko; Ogura, Toshio; Kamada, Yasuhiko; Makino, Hirofumi.

In: Endocrine Journal, Vol. 56, No. 1, 2009, p. 157-160.

Research output: Contribution to journalArticle

@article{4ea51e0da05c4a0ea1fd917c723a4b35,
title = "Effects of growth hormone reduction in a patient with polycystic ovary syndrome complicated with acromegaly",
abstract = "We report a rare case of polycystic ovary syndrome (PCOS) complicated with acromegaly due to a growth hormone (GH)-producing pituitary adenoma. Complete removal of the pituitary adenoma successfully reduced circulating levels of GH and insulin-like growth factor (IGF)-l, which, in turn, resulted in the amelioration of gonadal dysfunction, hyperandrogenism, lutenizing hormone hypersecretion, and severe insulin resistance. This clinical complication suggests that activation of systemic GH-IGF-1 axis is potentially involved in the development of PCOS.",
keywords = "Acromegaly, Growth hormone, Hyperglycemia, Insulin-like growth factor-1, Polycystic ovary syndrome",
author = "Junko Goto and Fumio Otsuka and Kenichi Inagaki and Naoko Tsukamoto and Jiro Suzuki and Tomoko Miyoshi and Toshio Ogura and Yasuhiko Kamada and Hirofumi Makino",
year = "2009",
doi = "10.1507/endocrj.K08E-215",
language = "English",
volume = "56",
pages = "157--160",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Effects of growth hormone reduction in a patient with polycystic ovary syndrome complicated with acromegaly

AU - Goto, Junko

AU - Otsuka, Fumio

AU - Inagaki, Kenichi

AU - Tsukamoto, Naoko

AU - Suzuki, Jiro

AU - Miyoshi, Tomoko

AU - Ogura, Toshio

AU - Kamada, Yasuhiko

AU - Makino, Hirofumi

PY - 2009

Y1 - 2009

N2 - We report a rare case of polycystic ovary syndrome (PCOS) complicated with acromegaly due to a growth hormone (GH)-producing pituitary adenoma. Complete removal of the pituitary adenoma successfully reduced circulating levels of GH and insulin-like growth factor (IGF)-l, which, in turn, resulted in the amelioration of gonadal dysfunction, hyperandrogenism, lutenizing hormone hypersecretion, and severe insulin resistance. This clinical complication suggests that activation of systemic GH-IGF-1 axis is potentially involved in the development of PCOS.

AB - We report a rare case of polycystic ovary syndrome (PCOS) complicated with acromegaly due to a growth hormone (GH)-producing pituitary adenoma. Complete removal of the pituitary adenoma successfully reduced circulating levels of GH and insulin-like growth factor (IGF)-l, which, in turn, resulted in the amelioration of gonadal dysfunction, hyperandrogenism, lutenizing hormone hypersecretion, and severe insulin resistance. This clinical complication suggests that activation of systemic GH-IGF-1 axis is potentially involved in the development of PCOS.

KW - Acromegaly

KW - Growth hormone

KW - Hyperglycemia

KW - Insulin-like growth factor-1

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=62549122109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549122109&partnerID=8YFLogxK

U2 - 10.1507/endocrj.K08E-215

DO - 10.1507/endocrj.K08E-215

M3 - Article

C2 - 18840925

AN - SCOPUS:62549122109

VL - 56

SP - 157

EP - 160

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 1

ER -